Related Image: New insights into a leading poultry disease and its risks to human health |
(Date:11/20/2009)...ass from the production of flax shives, and genera...ant related to those which engulf fields in spring... suggested by two studies carried out by Spanish a... Renewable and Sustainable Energy Reviews . , "Th...of view, the production of bioethanol from two, as...
(Date:11/19/2009)...ghly 15,000 years ago, at the end of the last ice ...als including such iconic creatures as mammoths, ... beavers began their precipitous slide to extinct...ing a land whose diversity of large animals equale...ains then or now, an entirely novel ecosystem emer...
(Date:11/19/2009)...ng Harbor, NY A four-year, multi-institutional ef... (CSHL) scientists culminated today in publication...ience revealing in unprecedented detail the DNA s...it is commonly called by North American consumers,...he most valuable agricultural crop grown in the Un...
Breaking Biology News(10 mins):Flax and yellow flowers can produce bioethanol 2After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4Florida Hospital Cardiovascular Institute Completes House Wide Implementation of the LifeSync 28R 29 Wireless ECG System 47699 1Florida Hospital Cardiovascular Institute Completes House Wide Implementation of the LifeSync 28R 29 Wireless ECG System 47699 2Florida Hospital Cardiovascular Institute Completes House Wide Implementation of the LifeSync 28R 29 Wireless ECG System 47699 3Understand ARRA Spending Allocations with HIMSS Analytics 26amp 3B 238482 3B Market Intelligence 47698 1Understand ARRA Spending Allocations with HIMSS Analytics 26amp 3B 238482 3B Market Intelligence 47698 2Understand ARRA Spending Allocations with HIMSS Analytics 26amp 3B 238482 3B Market Intelligence 47698 3Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 1Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 2(Date:11/19/2009)..., SEATTLE, Nov. 19 Omero...udited financial results for the third quarter end...September 30, 2009, Omeros reported a net loss of ... net loss of $7.4 million, or $2.54 per share, for...d September 30, 2009, the Company reported a net l...
(Date:11/19/2009)..., ,, BETHESDA, Md., Nov. 19 /PRNewswire-F..., an innovator in biotechnology for diabetes thera...sulting services to food, supplement, biotechnolog... closed the previously reported $6.3 million regis...of 2,760,870 shares of its common stock and warran...
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 ...or in biotechnology for diabetes therapy, and a pr...ices to food, supplement, biotechnology and pharma... Tuesday,s Annual Meeting of Shareholders. ,, A...d (Nasdaq: SPEX ) elected the following members t...
(Date:11/19/2009)..., MUNSTER, Germany, November 19 /PRNewswire...e filed on November 16th, 2009 Flibanserin in the,...kinesia in Parkinson,s,disease for orphan drug sta...,(EMEA). Levodopa-induced dyskinesia is a complica...on,s and a serious burden to some of those,affecte...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2...gae is a livid green giveaway of nutrient pollutio...at action in tiny particles that would turn differ...spoilage or signs of poor health in the blood. , ... have tapped the working parts of cells to clear a...eat, which signifies a new approach to technology ...
... N-Viro International Corporation,(OTC Bulletin B...ing company,that owns patented technologies to con...ative fuel products, announces its renewable biofu...elines set forth by the U.S.,Environmental Protect...gy,source that may be utilized in commercial power...
...vania and REHOVOT Israel, January 16, Rosetta Geno...y unveiled initial data relating to the company,s,...creen(TM) colon, which is,based on a simple blood ...e,company,s scientists and collaborators have iden...e potential to accurately differentiate colorectal...
Other Biology Technology:Researchers: Molecular forklifts overcome obstacle to 'smart dust' 2Researchers: Molecular forklifts overcome obstacle to 'smart dust' 3N-Viro Fuel Technology Receives Alternative Energy Status From the U.S. Environmental Protection Agency 2N-Viro Fuel Technology Receives Alternative Energy Status From the U.S. Environmental Protection Agency 3N-Viro Fuel Technology Receives Alternative Energy Status From the U.S. Environmental Protection Agency 4Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum 2Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum 3Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum 4Mouse Anti-Human Actopaxin, phospho (Ser8) Monoclonal Antibody, Unconjugated, Clone J160-366 from BD Biosciences Pharmingen
Anti-gp64 Antibody, Unconjugated from Novagen
Rabbit Anti-b-Catenin, phospho (Ser675) Antibody, Unconjugated from Spring Bioscience
Rabbit Anti-Human Naked1 Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Biology Products: